ArticleCancer immunology, immunotherapy : CII2023

Association of medical comorbidities and cardiovascular disease with toxicity and survival among patients receiving checkpoint inhibitor immunotherapy.

Andrew C Johns et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.